News

SNS JU 2024 work programme published

Published on | 2 years ago

Programmes Digital, Industry & Space

The 2024 topics of SNS (Smart Networks Europe) JU have now been published. Deadlines are showing as mid-April on the current text, presumably this will be updated soon to the real deadline.

Below you can find the call topics, read the full work programme text for more details.

Stream B - Research for revolutionary and evolutionary 6G Technology and systems

  • B-01-01: System Architecture - Standardisation and Follow-up/PoCs
  • B-01-02: Wireless Communication Technologies and Signal Processing – Standardisation and Follow-up/PoCs
  • B-01-03: Communication Infrastructure Technologies and Devices – Standardisation and Follow-up/PoCs
  • B-01-04: Reliable Services and Smart Security–Standardisation and Follow-up/PoCs
  • B-01-05: International Collaboration – EU-JP
  • B-01-06: International Collaboration – EU-ROK
  • B-01-07: Sustainability Lighthouse
  • B-01-08: Reliable AI for 6G Communications Systems and Services

Stream C – Smart Network & Services experimental infrastructure

  • C-01-01: SNS Microelectronics Lighthouse

Stream D – SNS Large Scale Trials and Pilots (LST&Ps) with Verticals

  • D-01-01: SNS Large Scale Trials and Pilots (LST&Ps) with Verticals

 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1759 articles available search in articles 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.